A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX).

被引：0
|
作者：
Hendifar, Andrew Eugene
Kim, Sungjin
Tighiouart, Mourad
Hautamaki, Emily
Kim, Haesoo
Ng, Camille
Liu, Jar-Yee
Scher, Kevin S.
Klempner, Samuel J.
Placencio-Hickok, Veronica
Gresham, Gillian
Gong, Jun
机构：
[1] Cedars Sinai Med Ctr, Samuel Oschin Canc Ctr, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, West Hollywood, CA USA
[4] Tower Hematol Oncol Med Grp, Beverly Hills, CA USA
[5] Angeles Clin & Res Inst, Los Angeles, CA USA
[6] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4634
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase II study of 5-Fluorouracil and high-dose folinic acid in combination with cyclophosphamide and mitoxantrone in advanced breast cancer
    Cavazzini, G
    Pagani, M
    Casarini, MB
    Aitini, E
    Cantore, M
    Rabbi, C
    Pari, F
    Paganini, G
    Zamagni, D
    Smerieri, F
    ANNALS OF ONCOLOGY, 1998, 9 : 27 - 28
  • [42] Phase I trial of gemcitabine (Gemzar®, 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer
    Oettle, H
    Pelzer, U
    Hochmuth, K
    Diebold, T
    Langrehr, J
    Schmidt, CA
    Arning, M
    Vogl, TJ
    Neuhaus, P
    Huhn, D
    Riess, H
    ANTI-CANCER DRUGS, 1999, 10 (08) : 699 - 704
  • [43] Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study
    Miki, Masami
    Fujimori, Nao
    Ueda, Keijiro
    Lee, Lingaku
    Murakami, Masatoshi
    Takamatsu, Yu
    Shimokawa, Yuzo
    Niina, Yusuke
    Oono, Takamasa
    Hisano, Terumasa
    Furukawa, Masayuki
    Ogawa, Yoshihiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [44] Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus
    Polee, MB
    Kok, TC
    Siersema, PD
    Tilanus, NW
    Splinter, TAW
    Stoter, G
    Van der Gaast, A
    ANTI-CANCER DRUGS, 2001, 12 (06) : 513 - 517
  • [45] Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
    Dank, M.
    Zaluski, J.
    Barone, C.
    Valvere, V.
    Yalcin, S.
    Peschel, C.
    Wenczl, M.
    Goker, E.
    Cisar, L.
    Wang, K.
    Bugat, R.
    ANNALS OF ONCOLOGY, 2008, 19 (08) : 1450 - 1457
  • [46] Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study
    Jean-Luc Raoul
    Jean-Luc Van Laethem
    Marc Peeters
    Catherine Brezault
    Fares Husseini
    Laurent Cals
    Johannes Nippgen
    Anja-Helena Loos
    Philippe Rougier
    BMC Cancer, 9
  • [47] TREATMENT OF ADVANCED COLORECTAL-CANCER - A PILOT CLINICAL-STUDY WITH 5-FLUOROURACIL AND FOLINIC ACID IN COMBINATION WITH INTERFERON-ALPHA
    TONINI, G
    NUNZIATA, C
    TURRIZIANI, M
    PRETE, SP
    PEPPONI, R
    DEVECCHIS, L
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1995, 14 (01) : 17 - 24
  • [48] Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study
    Raoul, Jean-Luc
    Van Laethem, Jean-Luc
    Peeters, Marc
    Brezault, Catherine
    Husseini, Fares
    Cals, Laurent
    Nippgen, Johannes
    Loos, Anja-Helena
    Rougier, Philippe
    BMC CANCER, 2009, 9
  • [49] Phase I Study of Cediranib in Combination with Oxaliplatin and Infusional 5-Fluorouracil in Patients with Advanced Colorectal Cancer
    Chen, Eric
    Jonker, Derek
    Gauthier, Isabelle
    MacLean, Martha
    Wells, Julie
    Powers, Jean
    Seymour, Lesley
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1481 - 1486
  • [50] A phase I study of etirinotecan pegol in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.
    Krishnamurthi, Smitha S.
    Chadha, Manpreet
    Rodal, Mary Beth
    Weiss, Glen J.
    Bokar, Joseph A.
    Jameson, Gayle S.
    Mast, Catherine Patricia
    Zhao, Carol
    Waluch, Bridget
    Hoch, Ute
    Hannah, Alison
    Dowlati, Afshin
    Meropol, Neal J.
    Ramanathan, Ramesh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345